What did BluGlass (ASX:BLG) announce regarding its recent capital raising?

BluGlass secured $6.6 million in total gross proceeds following the expiry of its listed options on 31 May 2026. The funding consists of $5.1 million from option holders exercising their options at $0.26, and $1.5 million from an options shortfall agreement with institutional partner Amery Partners.

How many new shares is BluGlass (ASX:BLG) issuing under the shortfall placement?

Under the shortfall agreement with Amery Partners, BluGlass is issuing 5,769,230 fully paid ordinary shares. These shortfall shares are being issued at a set price of $0.26 per share.

What are the "piggyback options" attached to the BluGlass shortfall shares?

Each shortfall share issued to Amery Partners includes one free-attaching, unquoted "piggyback option". These options have an exercise price of $0.38 and expire on 31 May 2028. However, their issuance is not guaranteed and remains subject to final shareholder approval.

How will BluGlass (ASX:BLG) use the $6.6 million in new proceeds?

Management will deploy the combined funds directly toward supporting ongoing working capital requirements. Additionally, the capital will be used to accelerate the commercial scale-up and delivery of the company's gallium nitride (GaN) laser contracts.

What does this capital raising mean for the BluGlass (ASX:BLG) balance sheet?

This $6.6 million inflow adds substantial liquidity and follows an upsized $8 million institutional placement completed in April. Together, these capital injections strengthen the balance sheet to fund near-term manufacturing operations without the immediate need for debt.

What are the main bull and bear points for BluGlass (ASX:BLG) after this news?

The bull case is a strengthened cash position to scale its world-record single-mode laser technology and convert its global sales pipeline. The bear case for retail traders is the immediate share dilution from the 5.76 million shortfall shares and potential further dilution if the $0.38 piggyback options are approved and exercised.

Image for illustrative purposes only. Not a real photo.

Australia's BluGlass secures $6.6M funding boost

Written by Mahathir BayenaPublished Jun. 7 2026Last Updated Jun. 8 2026

Australian semiconductor developer BluGlass (ASX:BLG) has capitalised on its recently expired listed options, bringing in a total of $6.6 million in gross proceeds.

The funding windfall comprises $5.1 million injected directly by option holders exercising their $0.26 options prior to the May 31 expiry, alongside an additional $1.5 million secured via an options shortfall agreement with institutional partner Amery Partners.

Under the shortfall placement, BluGlass will issue 5,769,230 fully paid ordinary shares at $0.26 per share.

In accordance with the original option terms, each shortfall share incorporates a free-attaching, unquoted "piggyback option" exercisable at $0.38 with an expiry date of May 31, 2028, subject to final shareholder approval at the company's upcoming 2026 annual general meeting.

The capital injection strongly complements an upsized $8 million institutional placement completed in April.

Management has confirmed that the combined proceeds will be deployed directly towards supporting working capital requirements and accelerating the commercial scale-up and delivery of its gallium nitride laser contracts.

BluGlass Executive Chair Omer Granit expressed strong confidence in the company's technical trajectory, noting that the high participation rate reflects widespread investor support for its cutting-edge, world-record single-mode laser performance.

Granit emphasised that the recapitalisation uniquely positions the global photonics supplier to advance its manufacturing capabilities and convert growing commercial pipelines across defence, industrial, and biomedical markets globally.